Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China · Delayed Price · Currency is CNY 33.20
+2.15 (6.92%)
Aug 25, 2026, 3:04 PM CST
SHE:300957 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 5,566 | 5,332 | 5,707 | 5,707 | 4,998 | 4,008 |
Other Revenue | 12.71 | 26.48 | 29.11 | 20.55 | 16.12 | 14.63 |
| 5,578 | 5,359 | 5,736 | 5,727 | 5,014 | 4,022 | |
Revenue Growth | 5.19% | -6.58% | 0.15% | 14.23% | 24.65% | 52.57% |
Cost of Revenue | 1,516 | 1,404 | 1,565 | 1,462 | 1,262 | 977.08 |
Gross Profit | 4,062 | 3,955 | 4,170 | 4,266 | 3,752 | 3,045 |
Selling, General & Admin | 3,201 | 3,171 | 3,379 | 3,023 | 2,391 | 1,926 |
Research & Development | 231.97 | 237.38 | 295.17 | 298.82 | 254.7 | 113.22 |
Other Operating Expenses | 36.94 | 73.46 | 63.06 | 47.45 | 54.71 | 52.12 |
Operating Expenses | 3,470 | 3,479 | 3,750 | 3,382 | 2,700 | 2,097 |
Operating Income | 592.6 | 475.48 | 420.76 | 883.6 | 1,052 | 948.45 |
Interest Expense | -6.41 | -18.29 | -17.59 | -4.97 | -4.75 | -4.19 |
Interest & Investment Income | 66.94 | 97.94 | 82.5 | 92.91 | 100.88 | 33.62 |
Currency Exchange Gain (Loss) | -2.06 | -2.1 | -1.23 | -0.72 | 0.03 | -0 |
Other Non Operating Income (Expenses) | -2.26 | -1.55 | -17.25 | -215.84 | -1.72 | -0.53 |
EBT Excluding Unusual Items | 648.81 | 551.47 | 467.2 | 754.97 | 1,147 | 977.35 |
Impairment of Goodwill | -30.55 | -30.55 | -90.69 | - | - | - |
Gain (Loss) on Sale of Investments | 18.53 | 42.57 | 177.55 | -17.24 | -5.52 | 10.8 |
Gain (Loss) on Sale of Assets | 4.24 | 2.65 | -4.15 | 0.69 | -0.03 | 0.52 |
Asset Writedown | -0.75 | -4 | -25 | - | - | - |
Other Unusual Items | 30.65 | 54.39 | 83.49 | 130.39 | 72.75 | 29.21 |
Pretax Income | 670.93 | 616.54 | 608.4 | 868.82 | 1,214 | 1,018 |
Income Tax Expense | 115.71 | 99.72 | 113.61 | 109.61 | 163.33 | 153.81 |
Earnings From Continuing Operations | 555.22 | 516.83 | 494.79 | 759.21 | 1,051 | 864.06 |
Minority Interest in Earnings | -4.37 | -11.11 | 8.26 | -2.42 | 0.8 | -1.14 |
Net Income | 550.86 | 505.72 | 503.05 | 756.8 | 1,051 | 862.92 |
Net Income to Common | 550.86 | 505.72 | 503.05 | 756.8 | 1,051 | 862.92 |
Net Income Growth | 107.13% | 0.53% | -33.53% | -28.02% | 21.83% | 58.77% |
Shares Outstanding (Basic) | 420 | 421 | 419 | 423 | 424 | 407 |
Shares Outstanding (Diluted) | 420 | 421 | 419 | 423 | 424 | 407 |
Shares Change | -0.30% | 0.53% | -0.85% | -0.27% | 4.15% | 13.09% |
EPS (Basic) | 1.31 | 1.20 | 1.20 | 1.79 | 2.48 | 2.12 |
EPS (Diluted) | 1.31 | 1.20 | 1.20 | 1.79 | 2.48 | 2.12 |
EPS Growth | 107.76% | 0% | -32.96% | -27.82% | 16.98% | 40.40% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 919.53 | 493.61 | 316.48 | 336.16 | 416.02 | 882.04 |
Free Cash Flow Per Share | 2.19 | 1.17 | 0.76 | 0.80 | 0.98 | 2.17 |
Dividend Per Share | 0.650 | 0.650 | 0.600 | 0.600 | 0.800 | 0.600 |
Dividend Growth | 8.33% | 8.33% | -0.08% | -24.94% | 33.33% | 33.33% |
Gross Margin | 72.82% | 73.80% | 72.71% | 74.48% | 74.83% | 75.71% |
Operating Margin | 10.62% | 8.87% | 7.34% | 15.43% | 20.99% | 23.58% |
Profit Margin | 9.88% | 9.44% | 8.77% | 13.21% | 20.97% | 21.45% |
Free Cash Flow Margin | 16.48% | 9.21% | 5.52% | 5.87% | 8.30% | 21.93% |
EBITDA | 731.38 | 585.1 | 536.65 | 954.32 | 1,110 | 968.11 |
EBITDA Margin | 13.11% | 10.92% | 9.36% | 16.66% | 22.15% | 24.07% |
D&A For EBITDA | 138.78 | 109.63 | 115.89 | 70.72 | 58.23 | 19.66 |
EBIT | 592.6 | 475.48 | 420.76 | 883.6 | 1,052 | 948.45 |
EBIT Margin | 10.62% | 8.87% | 7.34% | 15.43% | 20.99% | 23.58% |
Effective Tax Rate | 17.25% | 16.17% | 18.67% | 12.62% | 13.46% | 15.11% |
Revenue as Reported | 2,987 | 5,359 | 5,736 | 5,522 | 5,014 | 4,022 |
Advertising Expenses | - | - | - | - | 1,534 | 1,249 |